CDC reporting of IVF outcomes still misleading
IVF outcomes reported to, and made public by, the Center for Disease Control and Prevention (CDC) are highly inflated in some cases, and can be misleading, according to an analysis by the CHR researchers.
The study, recently published in the medical journal Reproductive Biomedicine Online, found that of the 458 IVF centers reporting outcomes to the CDC under a congressional mandate, 27 report a disproportionately high number of "embryo banking" cycles. By excluding "embryo banking" cycles in poor-prognosis patients from their statistics, the 27 centers were able to report IVF success rates far higher than the rates that include these banking cycles. CHR's analysis found that the 27 outlier centers' live birth rates would actually be below the median of the rest of the centers if the banking cycles were not excluded from their reporting.
As these outlier centers include some of the most prominent IVF centers with large market shares, CHR researchers in their paper urge the CDC to to ensure that patients have access to accurate information about IVF centers' real competencies.
This is a part of the June 2017 issue of the VOICE.
Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.
We have helped women bring over 17,800 babies into the world.Discover your treatment options
- Breaking News in ScienceLetter to President Biden and Secretary Designate of HHS, Xavier Becerra In a published letter (Santoro et al Reprod Sciences 2021; https:/doi.org/10.1007/s43032-021-00491-9), a
- More On COVID-19DOES THE BRITISH STRAIN B.1.1.7 INCREASE MORTALITY OVER D614G? A just published study by British investigators claims that not only infectivity of the
- Mild Ovarian StimulationTwo prominent voices in the fertility field known as longstanding supporters of mild ovarian stimulation were at it once again (Nargund and Fauser, Reprod Biomed Online 2020;41:569-571) when
- Brief Case Studies in Clinical InfertilityIs there a place for DHEA and CoQ10 in women undergoing “planned” egg-freezing? At CHR, women undergoing egg-freeing cycles undergo a very